DK1416917T3 - Vandig dispersion, der omfatter stabile nanopartikler af et vanduoplöseligt aktivt stof og en excipiens som middellangkædede triglycerider (MCT) - Google Patents
Vandig dispersion, der omfatter stabile nanopartikler af et vanduoplöseligt aktivt stof og en excipiens som middellangkædede triglycerider (MCT)Info
- Publication number
- DK1416917T3 DK1416917T3 DK02745697T DK02745697T DK1416917T3 DK 1416917 T3 DK1416917 T3 DK 1416917T3 DK 02745697 T DK02745697 T DK 02745697T DK 02745697 T DK02745697 T DK 02745697T DK 1416917 T3 DK1416917 T3 DK 1416917T3
- Authority
- DK
- Denmark
- Prior art keywords
- water
- mct
- excipient
- active substance
- aqueous dispersion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Dental Preparations (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0119081A GB0119081D0 (en) | 2001-08-06 | 2001-08-06 | Process |
GB0212463A GB0212463D0 (en) | 2002-05-30 | 2002-05-30 | Process |
PCT/GB2002/003583 WO2003013472A1 (en) | 2001-08-06 | 2002-08-01 | Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct) |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1416917T3 true DK1416917T3 (da) | 2007-09-17 |
Family
ID=26246405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02745697T DK1416917T3 (da) | 2001-08-06 | 2002-08-01 | Vandig dispersion, der omfatter stabile nanopartikler af et vanduoplöseligt aktivt stof og en excipiens som middellangkædede triglycerider (MCT) |
Country Status (20)
Country | Link |
---|---|
US (1) | US20050009908A1 (el) |
EP (1) | EP1416917B1 (el) |
JP (1) | JP4714412B2 (el) |
KR (1) | KR100914113B1 (el) |
CN (1) | CN1254233C (el) |
AT (1) | ATE365537T1 (el) |
AU (1) | AU2002317409B2 (el) |
BR (1) | BR0211705A (el) |
CA (1) | CA2456180C (el) |
CY (1) | CY1107059T1 (el) |
DE (1) | DE60220923T2 (el) |
DK (1) | DK1416917T3 (el) |
ES (1) | ES2287293T3 (el) |
HK (1) | HK1064048A1 (el) |
IL (2) | IL160103A0 (el) |
MX (1) | MXPA04001071A (el) |
NO (1) | NO20040484L (el) |
NZ (1) | NZ530916A (el) |
PT (1) | PT1416917E (el) |
WO (1) | WO2003013472A1 (el) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
GB0230088D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0230087D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302671D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0314057D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
WO2004111033A1 (en) * | 2003-06-18 | 2004-12-23 | Astrazeneca Ab | 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
GB0314261D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
WO2006069098A1 (en) * | 2004-12-22 | 2006-06-29 | Elan Pharma International Ltd. | Nanoparticulate bicalutamide formulations |
EP1915131A4 (en) * | 2005-08-12 | 2012-07-25 | Astrazeneca Ab | PROCESS |
WO2008013785A2 (en) * | 2006-07-24 | 2008-01-31 | Singh-Broemer And Company, Inc. | Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening |
US20100260691A1 (en) * | 2006-07-31 | 2010-10-14 | Narayanan Kolazi S | Aqueous compositions containing a hydrophobic material |
US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
US20100068287A1 (en) * | 2007-02-09 | 2010-03-18 | Astrazeneca Ab | Process for Preparation of a Stable Dispersion of Solid Amorphous Submicron Particles in an Aqueous Medium |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
WO2009011861A1 (en) * | 2007-07-16 | 2009-01-22 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
EP2244714A4 (en) * | 2008-02-08 | 2012-06-06 | Poniard Pharmaceuticals Inc | USE OF PICOPLATIN AND BEVACIZUMAB TO TREAT COLORECTAL CANCER |
BRPI1004808B1 (pt) * | 2010-10-27 | 2020-09-29 | Embrapa - Empresa Brasileira De Pesquisa Agropecuária | Composições baseadas em nanopartículas de própolis, processos de obtenção e uso |
CN107596518B (zh) | 2012-02-29 | 2021-04-23 | 普马特里克斯营业公司 | 可吸入干粉剂 |
KR102045732B1 (ko) * | 2012-12-28 | 2019-11-18 | 엘지디스플레이 주식회사 | 온도감응형 계면활성제를 이용한 수용성 나노입자의 제조방법 |
PT106738B (pt) * | 2013-01-09 | 2015-06-08 | Hovione Farmaciencia Sa | Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico |
CN105121559A (zh) * | 2013-02-08 | 2015-12-02 | 巴斯夫欧洲公司 | 通过反应喷雾干燥的无机/有机复合材料的制备 |
US20190110993A1 (en) * | 2017-09-12 | 2019-04-18 | Raj Selvaraj | Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening |
EP4426694A1 (en) | 2021-11-05 | 2024-09-11 | Cinclus Pharma Holding AB (publ) | Polymorphs of the hydrochloride salt of linaprazan glurate |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2224131B2 (de) * | 1972-05-17 | 1974-06-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur Gewinnung des Enzyms Cholesterinoxydase, welches Cholesterin mit O tief 2 zu Cholestenon und H tief 2 O tief 2 oxydiert |
US4348385A (en) * | 1980-11-17 | 1982-09-07 | Mobay Chemical Corporation | Flowable pesticides |
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
FR2608988B1 (fr) * | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
US4799962A (en) * | 1987-12-24 | 1989-01-24 | Aqualon Company | Water-soluble polymer dispersion |
US5145648A (en) * | 1988-06-28 | 1992-09-08 | Matsushita Electric Industrial Co., Ltd. | Exhaust smoke purifier apparatus |
FR2651680B1 (fr) * | 1989-09-14 | 1991-12-27 | Medgenix Group Sa | Nouveau procede de preparation de microparticules lipidiques. |
CA2044706C (en) * | 1990-06-15 | 2003-02-25 | Michael Midler Jr. | Crystallization method to improve crystal structure and size |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
WO1993010768A1 (de) * | 1991-12-05 | 1993-06-10 | Alfatec-Pharma Gmbh | Pharmazeutisch applizierbares nanosol und verfahren zu seiner herstellung |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5468604A (en) * | 1992-11-18 | 1995-11-21 | Eastman Kodak Company | Photographic dispersion |
GB9319129D0 (en) * | 1993-09-15 | 1993-11-03 | Dowelanco Ltd | Storage and dilution of stable aqueous dispersions |
SE9303281D0 (sv) * | 1993-10-07 | 1993-10-07 | Astra Ab | New formulation |
SE9403846D0 (sv) * | 1994-11-09 | 1994-11-09 | Univ Ohio State Res Found | Small particle formation |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5665331A (en) * | 1995-01-10 | 1997-09-09 | Nanosystems L.L.C. | Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
ATE257698T1 (de) * | 1996-10-03 | 2004-01-15 | Hermes Biosciences Inc | Hydrophile mikropartikel und verfahren zu deren herstellung |
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
US6267989B1 (en) * | 1999-03-08 | 2001-07-31 | Klan Pharma International Ltd. | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6607784B2 (en) * | 2000-12-22 | 2003-08-19 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US20060003012A9 (en) * | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302671D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
-
2002
- 2002-08-01 DE DE60220923T patent/DE60220923T2/de not_active Expired - Lifetime
- 2002-08-01 MX MXPA04001071A patent/MXPA04001071A/es active IP Right Grant
- 2002-08-01 AT AT02745697T patent/ATE365537T1/de active
- 2002-08-01 CN CNB028197941A patent/CN1254233C/zh not_active Expired - Fee Related
- 2002-08-01 WO PCT/GB2002/003583 patent/WO2003013472A1/en active IP Right Grant
- 2002-08-01 US US10/486,211 patent/US20050009908A1/en not_active Abandoned
- 2002-08-01 NZ NZ530916A patent/NZ530916A/en not_active IP Right Cessation
- 2002-08-01 DK DK02745697T patent/DK1416917T3/da active
- 2002-08-01 JP JP2003518482A patent/JP4714412B2/ja not_active Expired - Fee Related
- 2002-08-01 ES ES02745697T patent/ES2287293T3/es not_active Expired - Lifetime
- 2002-08-01 BR BR0211705-3A patent/BR0211705A/pt not_active IP Right Cessation
- 2002-08-01 AU AU2002317409A patent/AU2002317409B2/en not_active Ceased
- 2002-08-01 KR KR1020047001779A patent/KR100914113B1/ko not_active IP Right Cessation
- 2002-08-01 IL IL16010302A patent/IL160103A0/xx active IP Right Grant
- 2002-08-01 PT PT02745697T patent/PT1416917E/pt unknown
- 2002-08-01 CA CA2456180A patent/CA2456180C/en not_active Expired - Fee Related
- 2002-08-01 EP EP02745697A patent/EP1416917B1/en not_active Expired - Lifetime
-
2004
- 2004-01-28 IL IL160103A patent/IL160103A/en not_active IP Right Cessation
- 2004-02-03 NO NO20040484A patent/NO20040484L/no not_active Application Discontinuation
- 2004-09-08 HK HK04106826A patent/HK1064048A1/xx not_active IP Right Cessation
-
2007
- 2007-08-28 CY CY20071101106T patent/CY1107059T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1416917B1 (en) | 2007-06-27 |
CN1254233C (zh) | 2006-05-03 |
JP4714412B2 (ja) | 2011-06-29 |
AU2002317409B2 (en) | 2007-06-21 |
ATE365537T1 (de) | 2007-07-15 |
DE60220923D1 (de) | 2007-08-09 |
CA2456180A1 (en) | 2003-02-20 |
KR20040025739A (ko) | 2004-03-25 |
NO20040484L (no) | 2004-03-31 |
BR0211705A (pt) | 2004-09-28 |
EP1416917A1 (en) | 2004-05-12 |
DE60220923T2 (de) | 2008-03-06 |
WO2003013472A1 (en) | 2003-02-20 |
PT1416917E (pt) | 2007-08-16 |
HK1064048A1 (en) | 2005-01-21 |
KR100914113B1 (ko) | 2009-08-27 |
IL160103A0 (en) | 2004-06-20 |
CN1564677A (zh) | 2005-01-12 |
MXPA04001071A (es) | 2004-05-20 |
CY1107059T1 (el) | 2012-10-24 |
US20050009908A1 (en) | 2005-01-13 |
JP2005500362A (ja) | 2005-01-06 |
IL160103A (en) | 2008-11-26 |
ES2287293T3 (es) | 2007-12-16 |
NZ530916A (en) | 2005-07-29 |
CA2456180C (en) | 2011-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1416917T3 (da) | Vandig dispersion, der omfatter stabile nanopartikler af et vanduoplöseligt aktivt stof og en excipiens som middellangkædede triglycerider (MCT) | |
EP1829530A3 (en) | Stabilization of active agents by formulation into nanoparticulate form | |
BR0210948A (pt) | Micropartìculas de lignina para liberação controlada de ativos agrìcolas | |
WO2005060431A3 (en) | System and method for manipulating and processing materials using holographic optical trapping | |
EP2241308A3 (en) | Method for coating fine particle with lipid membrane | |
WO2006113808A3 (en) | Methods of making and modifying porous devices for biomedical applications | |
WO2000066679A3 (en) | Electrochromic media with concentration-enhanced stability, process for the preparation thereof and use in electrochromic devices | |
NZ593214A (en) | Compounds and Processes for preparing serine protease inhibitors | |
DE60234420D1 (de) | Haarbehandlungsmittel | |
WO2002060578A1 (fr) | Dispositif servant a activer une substance au moyen d'une structure active et dispositif servant a generer un gaz | |
AU2003230658A1 (en) | Microparticles and method for their production | |
WO2007142618A3 (en) | High concentrated, biocidally active compositions and aqueous mixtures and methods of making the same | |
WO2004084860A3 (en) | Methods for the comminution and stabilization of small particles in suspension | |
ATE399566T1 (de) | Stabile dispersion fester teilchen mit einer wasserunlöslichen pyrazin-verbindung | |
WO2005038948A3 (en) | Nanosized silver oxide powder | |
ATE449643T1 (de) | Verfahren zur stabilisierung von peroxycarbonsäuren in tensidhaltigen dispersionen | |
WO2001062088A3 (en) | Safening high concentrations of phytocatalysts | |
NO20060109L (no) | Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning | |
NO20030768L (no) | Fremgangsmåte for stabilisering av småpartikkelmateriale | |
ATE440594T1 (de) | Herstellung von kolloidale teilchen enthaltenden pulvern | |
ITSA20030013A1 (it) | Manufatti microporosi e nanoporosi a base di | |
DK1775285T3 (da) | Fremgangsmåde til krystallisation af bicalutamid | |
WO2005037446A3 (en) | Applying imprinting material to substrates employing electromagnetic fields | |
FI20010164A0 (fi) | Menetelmä parantuneen stabiliteetin omaavien natriumperkarbonaattirakeiden valmistamiseksi | |
JP2010126492A (ja) | 還元型CoQ10−CD包接体の製造方法 |